Bicycle Therapeutics plc (BCYC:NASDAQ) closed at $3.57 on October 15, 2026, up 1.57% on the day. The stock trades 60.7% below its 52-week high of $9.08 and 7.1% above its 52-week low of $3.33. Over the past year, it lost 58.2%. Bicycle Therapeutics plc is part of the Health Care sector (Major Pharmaceuticals).
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -7.63% | -4.36% | -16.63% | -33.65% | -58.16% |
In 252 trading sessions since October 14, 2025, BCYC closed higher on 113 days (45%). Its best day was October 5, 2026 (+18.64%) and its worst was November 5, 2025 (-10.19%). The stock moved 10% or more in a single session 3 times.
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical need.
Find more stocks like BCYC with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.